BIRC3 and BIRC5: multi‐faceted inhibitors in cancer

by Raffaele Frazzi
Published 2021-01-01

SIRT1 in Secretory Organ Cancer

by Raffaele Frazzi
Published 2018-09-01

Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells

by Raffaele Frazzi, Manuela Guardi
Published 2017-05-01

The Multiple Mechanisms of Cell Death Triggered by Resveratrol in Lymphoma and Leukemia

by Raffaele Frazzi, Marco Tigano
Published 2014-03-01

Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases

by Allan Lançon, Raffaele Frazzi, Norbert Latruffe
Published 2016-03-01

Copy Number Variation and Rearrangements Assessment in Cancer: Comparison of Droplet Digital PCR with the Current Approaches

by Vincenza Ylenia Cusenza, Alessandra Bisagni, Monia Rinaldini, Chiara Cattani, Raffaele Frazzi
Published 2021-04-01